Artivion, Inc. (AORT)
23.09
+0.81
(+3.64%)
USD |
NYSE |
Oct 20, 16:00
23.16
+0.06
(+0.28%)
Pre-Market: 20:00
Artivion Gross Profit (TTM) : 288.41M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 288.41M |
| March 31, 2026 | 281.80M |
| December 31, 2025 | 270.45M |
| September 30, 2025 | 258.09M |
| June 30, 2025 | 244.03M |
| March 31, 2025 | 233.72M |
| December 31, 2024 | 232.46M |
| September 30, 2024 | 232.51M |
| June 30, 2024 | 228.02M |
| March 31, 2024 | 222.80M |
| December 31, 2023 | 213.58M |
| September 30, 2023 | 203.48M |
| June 30, 2023 | 196.04M |
| March 31, 2023 | 190.03M |
| December 31, 2022 | 186.82M |
| September 30, 2022 | 186.82M |
| June 30, 2022 | 185.28M |
| March 31, 2022 | 183.27M |
| December 31, 2021 | 180.20M |
| September 30, 2021 | 173.20M |
| June 30, 2021 | 169.37M |
| March 31, 2021 | 155.98M |
| December 31, 2020 | 153.53M |
| September 30, 2020 | 156.77M |
| June 30, 2020 | 159.58M |
| Date | Value |
|---|---|
| March 31, 2020 | 171.26M |
| December 31, 2019 | 171.98M |
| September 30, 2019 | 171.07M |
| June 30, 2019 | 168.70M |
| March 31, 2019 | 167.39M |
| December 31, 2018 | 162.19M |
| September 30, 2018 | 154.30M |
| June 30, 2018 | 143.01M |
| March 31, 2018 | 131.68M |
| December 31, 2017 | 123.56M |
| September 30, 2017 | 118.90M |
| June 30, 2017 | 118.80M |
| March 31, 2017 | 116.18M |
| December 31, 2016 | 114.47M |
| September 30, 2016 | 110.33M |
| June 30, 2016 | 104.18M |
| March 31, 2016 | 96.09M |
| December 31, 2015 | 88.58M |
| September 30, 2015 | 84.79M |
| June 30, 2015 | 85.61M |
| March 31, 2015 | 86.44M |
| December 31, 2014 | 89.26M |
| September 30, 2014 | 88.94M |
| June 30, 2014 | 88.50M |
| March 31, 2014 | 87.60M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Alphatec Holdings, Inc. | 500.18M |
| Glaukos Corp. | 484.88M |
| TransMedics Group, Inc. | 386.06M |
| Embecta Corp. | 607.50M |
| Abbott Laboratories | 24.60B |